nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0459	0.0459	CcSEcCtD
Sotalol—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.0459	0.0459	CcSEcCtD
Sotalol—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.0405	0.0405	CcSEcCtD
Sotalol—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.0374	0.0374	CcSEcCtD
Sotalol—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0357	0.0357	CcSEcCtD
Sotalol—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0336	0.0336	CcSEcCtD
Sotalol—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0262	0.0262	CcSEcCtD
Sotalol—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0257	0.0257	CcSEcCtD
Sotalol—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0229	0.0229	CcSEcCtD
Sotalol—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0216	0.0216	CcSEcCtD
Sotalol—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0209	0.0209	CcSEcCtD
Sotalol—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0197	0.0197	CcSEcCtD
Sotalol—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0194	0.0194	CcSEcCtD
Sotalol—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0187	0.0187	CcSEcCtD
Sotalol—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0184	0.0184	CcSEcCtD
Sotalol—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0177	CcSEcCtD
Sotalol—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0168	CcSEcCtD
Sotalol—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0162	0.0162	CcSEcCtD
Sotalol—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0161	0.0161	CcSEcCtD
Sotalol—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0157	0.0157	CcSEcCtD
Sotalol—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.015	0.015	CcSEcCtD
Sotalol—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0147	CcSEcCtD
Sotalol—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0146	0.0146	CcSEcCtD
Sotalol—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0142	CcSEcCtD
Sotalol—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0141	CcSEcCtD
Sotalol—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0141	CcSEcCtD
Sotalol—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0134	CcSEcCtD
Sotalol—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0131	CcSEcCtD
Sotalol—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0124	CcSEcCtD
Sotalol—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0115	CcSEcCtD
Sotalol—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Sotalol—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0111	CcSEcCtD
Sotalol—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.011	0.011	CcSEcCtD
Sotalol—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Sotalol—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0108	CcSEcCtD
Sotalol—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0106	CcSEcCtD
Sotalol—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Sotalol—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Sotalol—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Sotalol—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00993	0.00993	CcSEcCtD
Sotalol—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00988	0.00988	CcSEcCtD
Sotalol—Cough—Hydrochlorothiazide—nephrolithiasis	0.00981	0.00981	CcSEcCtD
Sotalol—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00957	0.00957	CcSEcCtD
Sotalol—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00957	0.00957	CcSEcCtD
Sotalol—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00954	0.00954	CcSEcCtD
Sotalol—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00917	0.00917	CcSEcCtD
Sotalol—Shock—Hydrochlorothiazide—nephrolithiasis	0.00903	0.00903	CcSEcCtD
Sotalol—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00898	0.00898	CcSEcCtD
Sotalol—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00887	0.00887	CcSEcCtD
Sotalol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00857	0.00857	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00836	0.00836	CcSEcCtD
Sotalol—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0083	0.0083	CcSEcCtD
Sotalol—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00824	0.00824	CcSEcCtD
Sotalol—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00818	0.00818	CcSEcCtD
Sotalol—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00816	0.00816	CcSEcCtD
Sotalol—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00808	0.00808	CcSEcCtD
Sotalol—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00798	0.00798	CcSEcCtD
Sotalol—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00791	0.00791	CcSEcCtD
Sotalol—Pain—Hydrochlorothiazide—nephrolithiasis	0.00785	0.00785	CcSEcCtD
Sotalol—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0075	0.0075	CcSEcCtD
Sotalol—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00725	0.00725	CcSEcCtD
Sotalol—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00725	0.00725	CcSEcCtD
Sotalol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00658	0.00658	CcSEcCtD
Sotalol—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00649	0.00649	CcSEcCtD
Sotalol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00628	0.00628	CcSEcCtD
Sotalol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00607	0.00607	CcSEcCtD
Sotalol—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00583	0.00583	CcSEcCtD
Sotalol—Rash—Hydrochlorothiazide—nephrolithiasis	0.00578	0.00578	CcSEcCtD
Sotalol—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00578	0.00578	CcSEcCtD
Sotalol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00575	0.00575	CcSEcCtD
Sotalol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00545	0.00545	CcSEcCtD
